Influenza virus sialidase: effect of calcium on steady-state kinetic parameters
- PMID: 2009295
- DOI: 10.1016/0167-4838(91)90526-6
Influenza virus sialidase: effect of calcium on steady-state kinetic parameters
Abstract
Ca2+ increases the initial rate of activity of sialidase from influenza virus (A/Tokyo/3/67). Increasing ionic strength also activates influenza virus sialidase. When ionic strength is controlled, smaller but still significant Ca2+ effects are observed, with Vmax/Km increased from 0.8.10(5) to 1.4.10(5) M-1 s-1 and Vmax increased from 6.3 to 9.5 s-1 by saturating Ca2+. The Ki of the competitive inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid was decreased from 2.7.10(-6) to 1.15.10(-6) M after the addition of saturating Ca2+. The data show that Ca2+ exerts a specific effect on Vmax/Km, leading to an increased rate of interaction of substrate with the enzyme. The Kd-app for the Ca2(+)-sialidase complex is 2 mM. Except for Mg2+ which behaves similarly to Ca2+, other mono- and divalent cations have little specific effect on sialidase kinetics. Sequence analysis of a range of subtypes of sialidases from influenza virus supports the proposal that Ca2+ binds at the subunit interface transmitting a conformational change to the enzyme active site. Ca2+ activation may have a physiological role in switching on sialidase activity during the release of newly synthesised virions from the host cell surface.
Similar articles
-
Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9852-6. doi: 10.1073/pnas.90.21.9852. Proc Natl Acad Sci U S A. 1993. PMID: 8234325 Free PMC article.
-
Characterisation of an ionisable group involved in binding and catalysis by sialidase from influenza virus.Biochem Int. 1991 May;24(1):165-71. Biochem Int. 1991. PMID: 1768256
-
Kinetic studies on the sialidase of three influenza B and three influenza A virus strains.Glycoconj J. 1989;6(2):219-27. doi: 10.1007/BF01050650. Glycoconj J. 1989. PMID: 2535486
-
Inhibition of sialidase activity as a therapeutic approach.Drug Des Devel Ther. 2018 Oct 10;12:3431-3437. doi: 10.2147/DDDT.S176220. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30349196 Free PMC article. Review.
-
Low-pH Stability of Influenza A Virus Sialidase Contributing to Virus Replication and Pandemic.Biol Pharm Bull. 2015;38(6):817-26. doi: 10.1248/bpb.b15-00120. Biol Pharm Bull. 2015. PMID: 26027822 Review.
Cited by
-
Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.J Virol. 2016 Sep 29;90(20):9457-70. doi: 10.1128/JVI.01346-16. Print 2016 Oct 15. J Virol. 2016. PMID: 27512075 Free PMC article.
-
Influenza neuraminidase.Influenza Other Respir Viruses. 2012 Jul;6(4):245-56. doi: 10.1111/j.1750-2659.2011.00304.x. Epub 2011 Nov 16. Influenza Other Respir Viruses. 2012. PMID: 22085243 Free PMC article. Review.
-
The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.EMBO J. 1992 Jan;11(1):49-56. doi: 10.1002/j.1460-2075.1992.tb05026.x. EMBO J. 1992. PMID: 1740114 Free PMC article.
-
DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.Biochem J. 2018 Dec 10;475(23):3847-3860. doi: 10.1042/BCJ20180764. Biochem J. 2018. PMID: 30404922 Free PMC article.
-
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.Front Immunol. 2021 Nov 16;12:786617. doi: 10.3389/fimmu.2021.786617. eCollection 2021. Front Immunol. 2021. PMID: 34868073 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
